Wu X - Search Results

1

Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate.

Wu X, Balu N, Li W, Chen Y, Shi X, Kummitha CM, Yu X, Yuan C, Lu ZR. Wu X, et al. Am J Nucl Med Mol Imaging. 2013 Sep 19;3(5):446-55. eCollection 2013. Am J Nucl Med Mol Imaging. 2013. PMID: 24116353 Free PMC article.

2

Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.

Wu X, Yu G, Lindner D, Brady-Kalnay SM, Zhang Q, Lu ZR. Wu X, et al. Am J Nucl Med Mol Imaging. 2014 Jul 15;4(6):525-36. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 25250202 Free PMC article.

3

Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.

Tan M, Wu X, Jeong EK, Chen Q, Lu ZR. Tan M, et al. Among authors: wu x. Biomacromolecules. 2010 Mar 8;11(3):754-61. doi: 10.1021/bm901352v. Biomacromolecules. 2010. PMID: 20131758 Free PMC article.

4

Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.

Wu X, Zong Y, Ye Z, Lu ZR. Wu X, et al. Pharm Res. 2010 Jul;27(7):1390-7. doi: 10.1007/s11095-010-0131-9. Pharm Res. 2010. PMID: 20393871 Free PMC article.

5

An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.

Tan M, Wu X, Jeong EK, Chen Q, Parker DL, Lu ZR. Tan M, et al. Among authors: wu x. Mol Pharm. 2010 Aug 2;7(4):936-43. doi: 10.1021/mp100054m. Mol Pharm. 2010. PMID: 20481565 Free PMC article.

6

Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.

Lu ZR, Wu X. Lu ZR, et al. Among authors: wu x. Isr J Chem. 2010 Aug;50(2):220-232. doi: 10.1002/ijch.201000016. Isr J Chem. 2010. PMID: 21331318 Free PMC article.

7

Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.

Tan M, Ye Z, Jeong EK, Wu X, Parker DL, Lu ZR. Tan M, et al. Among authors: wu x. Bioconjug Chem. 2011 May 18;22(5):931-7. doi: 10.1021/bc100573t. Epub 2011 Apr 19. Bioconjug Chem. 2011. PMID: 21473650 Free PMC article.

8

MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.

Tan M, Burden-Gulley SM, Li W, Wu X, Lindner D, Brady-Kalnay SM, Gulani V, Lu ZR. Tan M, et al. Among authors: wu x. Pharm Res. 2012 Apr;29(4):953-60. doi: 10.1007/s11095-011-0635-y. Epub 2011 Dec 3. Pharm Res. 2012. PMID: 22139536 Free PMC article.

9

Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.

Wu X, Burden-Gulley SM, Yu GP, Tan M, Lindner D, Brady-Kalnay SM, Lu ZR. Wu X, et al. Bioconjug Chem. 2012 Aug 15;23(8):1548-56. doi: 10.1021/bc300009t. Epub 2012 Aug 1. Bioconjug Chem. 2012. PMID: 22812444 Free PMC article.

10

Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.

Ye Z, Wu X, Tan M, Jesberger J, Grisworld M, Lu ZR. Ye Z, et al. Among authors: wu x. Contrast Media Mol Imaging. 2013 May-Jun;8(3):220-8. doi: 10.1002/cmmi.1520. Contrast Media Mol Imaging. 2013. PMID: 23606425 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,488 results

Search Page

Filters